21 Mar 2018 11:40
21 March 2018
ARIX BIOSCIENCE PLC
Director/PDMR Shareholding
PDMR DEALING NOTIFICATION | |||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Jonathan Peacock | |
2 | Reason for the notification | ||
a) | Position / status | Chairman | |
b) | Initial notification / Amendment | Initial Notification | |
3 | Details of issuer | ||
a) | Name | Arix Bioscience plc | |
b) | LEI | 213800OVT3AHQCXNIX43 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of Arix Bioscience plc | |
Identification code | GB00BD045071 | ||
b) | Nature of the transaction | Purchase of Ordinary Shares | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
225.00 pence | 90,000 | ||
d) | Aggregated information | Aggregated price | Aggregated volume |
N/A (single transaction) | N/A (single transaction) | ||
e) | Date of the transaction | 20 March 2018 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
For further information:
James Rawlingson Chief Financial Officer +44 (0)207 290 1050
- Ends -